These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 3349171)

  • 1. [Heterogeneity of murine sarcoma cells for transplantability due to their different susceptibilities to the lytic action of macrophages].
    Ustinov AS; Lavrovskiĭ VA
    Biull Eksp Biol Med; 1988 Mar; 105(3):322-4. PubMed ID: 3349171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common transplantation antigens on methylcholanthrene-induced murine sarcomas detected by three assays of tumor rejection.
    Leffell MS; Coggin JH
    Cancer Res; 1977 Nov; 37(11):4112-9. PubMed ID: 908044
    [No Abstract]   [Full Text] [Related]  

  • 3. [The rate of macrophage inclusion in the elimination of tumor cells when administered to syngeneic animals].
    Lavrovskiĭ VA; Ustinov AS
    Eksp Onkol; 1990; 12(5):35-6. PubMed ID: 2226255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous decrease of tumor-specific antigenicity and "hybrid effect" in a murine methylcholanthrene-induced sarcoma.
    Oth D; Donner M; Burg C
    Transplantation; 1969 Nov; 8(5):742-5. PubMed ID: 5403331
    [No Abstract]   [Full Text] [Related]  

  • 5. Histological modifications of the lymph nodes in mice bearing syngeneic grafts of tumours induced by methylcholanthrene.
    Simar LJ; Focan C; Boniver J; Betz EH
    Pathol Eur; 1975; 10(4):317-25. PubMed ID: 1208123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor suppression by pyran copolymer: correlation with production of cytotoxic macrophages.
    Harmel RP; zbar B
    J Natl Cancer Inst; 1975 Apr; 54(4):989-92. PubMed ID: 1127729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune status of autochthonous and adoptively protected mice toward spontaneous and chemically induced tumors.
    Basombrío MA; Prehn RT
    Cancer Res; 1972 Nov; 32(11):2545-50. PubMed ID: 5082598
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunogenic strength of sarcomas induced by methylcholanthrene in millipore filter diffusion chambers.
    Parmiani G; Carbone G; Lembo R
    Cancer Res; 1973 Apr; 33(4):750-4. PubMed ID: 4696474
    [No Abstract]   [Full Text] [Related]  

  • 9. Evidence of common antigenic properties in chemically induced sarcomas of mice.
    Reiner J; Southam CM
    Cancer Res; 1967 Jul; 27(7):1243-7. PubMed ID: 4952516
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative analysis of the sensitivity to natural killers and macrophages of 3-methylcholanthrene-induced tumors in mice].
    Viksler VKh; Iaroslavtseva OA; Lavroskiĭ VA
    Eksp Onkol; 1986; 8(6):36-40. PubMed ID: 3803287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antibodies against cells of methylcholanthrene sarcoma in the blood of intact mice].
    Fedorovskaia MI; Vetrova EP; Umanskii IuA
    Biull Eksp Biol Med; 1973 Jul; 76(7):78-80. PubMed ID: 4774443
    [No Abstract]   [Full Text] [Related]  

  • 12. Tumor-specific and allospecific immunogenicity of soluble extracts from chemically induced murine sarcomas.
    Pellis NR; Tom BH; Kahan BD
    J Immunol; 1974 Aug; 113(2):708-11. PubMed ID: 4136043
    [No Abstract]   [Full Text] [Related]  

  • 13. Leukemoid reaction in BALB/c mice bearing primary tumors induced by 3-methylcholanthrene.
    Kodama T; Kawamura T; Kobayashi H
    Cancer Res; 1978 Mar; 38(3):713-5. PubMed ID: 626975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunity to a 3-methylcholanthrene-induced fibrosarcoma in the C57BL/6 mouse: in vivo analysis by the adoptive tumor neutralization test.
    Poupon MF; Lespinats G; Kolb JP; Payelle B
    J Natl Cancer Inst; 1979 Apr; 62(4):989-94. PubMed ID: 311871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment and immunologic characterization of 3-methylcholanthrene-induced sarcoma cell lines metastasizing widely in mice and exhibiting distinct and selective propensities for the mode of metastasis.
    Kodama Y; Seyama T; Kamiya K; Yokoro K
    J Natl Cancer Inst; 1982 Sep; 69(3):595-605. PubMed ID: 7050499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specificity of homograft rejection in vivo, assessed by inoculation of artificially mixed compatible and imcompatible tumor cells.
    Klein E; Klein G
    Cell Immunol; 1972 Sep; 5(1):201-8. PubMed ID: 5078988
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on transplantation immunity of methylcholanthrene-induced tumor by use of transplantation in lymph nodes and of diffusion chamber.
    Kitano M; Okada Y; Nagaishi C
    Exp Med Surg; 1969; 27(4):357-83. PubMed ID: 5384538
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of 51Cr-labelled macrophages for the objective evaluation of macrophage migration inhibition].
    Suslov AP; Miuller U
    Biull Eksp Biol Med; 1978 Jan; 85(1):54-7. PubMed ID: 342006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular reactions to methylcholanthrene-induced sarcomas transplanted to isogenic mice.
    Rosenau W; Moon HD
    Lab Invest; 1966 Jul; 15(7):1212-24. PubMed ID: 5947068
    [No Abstract]   [Full Text] [Related]  

  • 20. Immune status of the primary host toward its own methylcholanthrene-induced sarcomas.
    Stjernswärd J
    J Natl Cancer Inst; 1968 Jan; 40(1):13-22. PubMed ID: 5635014
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.